Omega Fund Management, LLC Long-Term Concentrated

CIK: 0001637359 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 3, 2016

Total Value ($000): $134,798 (100.0% shares, 0.0% debt)

Holdings (11)

— Juno Therapeutics 35.1%

Value ($000) $47,262 Shares 1,229,512 Est. Cost $52.22 Unrealized —

— Paratek Pharmaceuticals 26.8%

Value ($000) $36,172 Shares 2,600,410 Est. Cost $34.18 Unrealized —

— Egalet 10.6%

Value ($000) $14,334 Shares 2,889,926 Est. Cost $5.98 Unrealized —

— FibroGen 10.0%

Value ($000) $13,492 Shares 822,175 Est. Cost $27.34 Unrealized —

— Nabriva Therapeutics 6.4%

Value ($000) $8,594 Shares 1,145,890 Est. Cost $9.50 Unrealized —

— ESSA Pharma 3.7%

Value ($000) $5,006 Shares 1,696,969 Est. Cost $5.22 Unrealized —

— Pieris Pharmaceuticals 2.7%

Value ($000) $3,643 Shares 2,262,832 Est. Cost $1.83 Unrealized —

EDIT Editas Medicine 1.9%

Value ($000) $2,562 Shares 105,008 Est. Cost $26.29 Unrealized +28.3%

— Proteon Therapeutics 1.5%

Value ($000) $2,008 Shares 250,000 Est. Cost $10.40 Unrealized —

— CymaBay Therapeutics 0.8%

Value ($000) $1,055 Shares 606,100 Est. Cost $1.94 Unrealized —

— Dicerna Pharmaceuticals 0.5%

Value ($000) $670 Shares 223,457 Est. Cost $16.47 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	Juno Therapeutics	1,229,512	$47,262	35.1%	$52.22	—	Common Stock	48205A109
—	Paratek Pharmaceuticals	2,600,410	$36,172	26.8%	$34.18	—	Common Stock	699374302
—	Egalet	2,889,926	$14,334	10.6%	$5.98	—	Common Stock	28226B104
—	FibroGen	822,175	$13,492	10.0%	$27.34	—	Common Stock	31572Q808
—	Nabriva Therapeutics	1,145,890	$8,594	6.4%	$9.50	—	Sponsored ADR	62957M104
—	ESSA Pharma	1,696,969	$5,006	3.7%	$5.22	—	Common Stock	29668H104
—	Pieris Pharmaceuticals	2,262,832	$3,643	2.7%	$1.83	—	Common Stock	720795103
EDIT	Editas Medicine	105,008	$2,562	1.9%	$26.29	+28.3%	Common Stock	28106W103
—	Proteon Therapeutics	250,000	$2,008	1.5%	$10.40	—	Common Stock	74371L109
—	CymaBay Therapeutics	606,100	$1,055	0.8%	$1.94	—	Common Stock	23257D103
—	Dicerna Pharmaceuticals	223,457	$670	0.5%	$16.47	—	Common Stock	253031108